- Home
- LIVN vs GOF Comparison
LIVN vs GOF Comparison
Compare LIVN & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LIVN | GOF |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 2.0B |
| IPO Year | 2015 | 2006 |
Fundamental Metrics
Financial Performance| Metric | LIVN | GOF |
|---|---|---|
| Price | $90.87 | $8.99 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $90.55 | N/A |
| AVG Volume (30 Days) | 712.9K | ★ 1.8M |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.93 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.65 | N/A |
| Revenue Next Year | $7.10 | N/A |
| P/E Ratio | $32.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.83 | $8.40 |
| 52 Week High | $99.38 | $13.35 |
Technical Indicators
Market Signals| Indicator | LIVN | GOF |
|---|---|---|
| Relative Strength Index (RSI) | 68.94 | 55.38 |
| Support Level | $74.47 | $8.96 |
| Resistance Level | N/A | $10.74 |
| Average True Range (ATR) | 3.16 | 0.16 |
| MACD | 1.35 | 0.06 |
| Stochastic Oscillator | 59.72 | 64.68 |
Price Performance
Historical ComparisonAbout LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The Fund's investment objective is to maximize total return through a combination of current income and capital appreciation. It has single operating segment. Its products are Mutual Funds, Wealth Management SMAS, Institutional SMAS, ETFS, UITS, UCITS, CIT, Closed-End Funds, Private Funds, Rydex Funds, and Variable Insurance funds.